Cargando…

Network meta-analysis of migraine disorder treatment by NSAIDs and triptans

BACKGROUND: Migraine is a neurological disorder resulting in large socioeconomic burden. This network meta-analysis (NMA) is designed to compare the relative efficacy and tolerability of non-steroidal anti-inflammatory agents (NSAIDs) and triptans. METHODS: We conducted systematic searches in databa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Haiyang, Han, Wei, Wang, Jinghua, Li, Mingxian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153398/ https://www.ncbi.nlm.nih.gov/pubmed/27957624 http://dx.doi.org/10.1186/s10194-016-0703-0

Ejemplares similares

Polymorphisms of the Proinflammatory Cytokine Genes Modulate the Response to NSAIDs but Not to Triptans in Migraine Attacks
por: Rubino, Elisa, et al.
Publicado: (2022)

Network meta-analysis of success rate and safety in antibiotic treatments of bronchitis
por: Wang, Jinghua, et al.
Publicado: (2017)

Triptans in prevention of menstrual migraine: a systematic review with meta-analysis
por: Hu, Yong, et al.
Publicado: (2013)

Comparison of New Pharmacologic Agents With Triptans for Treatment of Migraine: A Systematic Review and Meta-analysis
por: Yang, Chun-Pai, et al.
Publicado: (2021)

Stroke, Migraine and Triptans: From Bedside to Bench
por: Raschi, Emanuel, et al.
Publicado: (2016)

Lasmiditan for the acute treatment of migraine: Subgroup analyses by prior response to triptans
por: Knievel, Kerry, et al.
Publicado: (2019)

Headaches related to triptans therapy in patients of migrainous vertigo
por: Prakash, Sanjay, et al.
Publicado: (2008)

Efficacy of frovatriptan as compared to other triptans in migraine with aura
por: Evers, Stefan, et al.
Publicado: (2015)

Acute treatment patterns in patients with migraine newly initiating a triptan
por: Lipton, Richard B, et al.
Publicado: (2020)

Lasmiditan for Patients with Migraine and Contraindications to Triptans: A Post Hoc Analysis
por: Krege, John H., et al.
Publicado: (2022)

Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine
por: Gentile, Giovanna, et al.
Publicado: (2010)

Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine
por: Gentile, Giovanna, et al.
Publicado: (2010)

Development and validation of a pharmacy migraine questionnaire to assess suitability for treatment with a triptan
por: Diener, Hans-Christoph, et al.
Publicado: (2008)

Triptans Use for Migraine Headache among Nonelderly Adults with Cardiovascular Risk
por: Alwhaibi, Monira, et al.
Publicado: (2016)

Up to date on the use of triptans for child and adolescent migraine: state of the art
por: Calderoni, Dario, et al.
Publicado: (2001)

Costs and Utilization of Triptan Users Who Receive Drug Prophylaxis for Migraine Versus Triptan Users Who Do Not Receive Drug Prophylaxis
por: Etemad, Lida R., et al.
Publicado: (2005)

Theoretical analysis of headache recurrence in patients administered triptans for migraine based on receptor occupancy
por: Tokuoka, Kentaro, et al.
Publicado: (2015)

Patients’ preference for triptans and other medications as a tool for assessing the efficacy of acute treatments for migraine
por: Dowson, A. J., et al.
Publicado: (2005)

Adding acute treatments for patients on triptans: Results of the American Migraine Prevalence & Prevention (AMPP) study
por: Lipton, RB, et al.
Publicado: (2013)

Evaluation of Patients with Insufficient Efficacy and/or Tolerability to Triptans for the Acute Treatment of Migraine: A Systematic Literature Review
por: Leroux, Elizabeth, et al.
Publicado: (2020)

Hair analysis for detection of triptans occasionally used or overused by migraine patients—a pilot study
por: Ferrari, Anna, et al.
Publicado: (2016)

European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure
por: Sacco, Simona, et al.
Publicado: (2022)

Meta-analysis of Oral Triptan Therapy for Migraine: Number Needed to Treat and Relative Cost to Achieve Relief Within 2 Hours
por: Adelman, James U., et al.
Publicado: (2003)

Dihydroergotamine and triptan use to treat migraine during pregnancy and the risk of adverse pregnancy outcomes
por: Bérard, Anick, et al.
Publicado: (2021)

Perinatal use of triptans and other drugs for migraine—A nationwide drug utilization study
por: Tauqeer, Fatima, et al.
Publicado: (2021)

Multi-omic analyses of triptan-treated migraine attacks gives insight into molecular mechanisms
por: Kogelman, Lisette J. A., et al.
Publicado: (2023)

All triptans are not the same
por: Rapoport, Alan M., et al.
Publicado: (2001)

Clinical experience with triptans
por: Zanchin, Giorgio, et al.
Publicado: (2001)

Different characteristics of triptans
por: Pini, Luigi A., et al.
Publicado: (2004)

Success and failure of triptans
por: Saxena, Pramod R., et al.
Publicado: (2001)

Selecting the preferred triptans
por: McCrory, Douglas C., et al.
Publicado: (2004)

Consistency vs. switching triptan treatment and headache-related disability: Results of the American migraine prevalence & prevention study
por: Buse, DC, et al.
Publicado: (2013)

Frovatriptan vs other triptans in the treatment of menstrual migraine: pooled analysis of three double-blind, randomized, cross-over studies
por: Allais, G, et al.
Publicado: (2013)

Managing migraine with over-the-counter provision of triptans: the perspectives and readiness of Western Australian community pharmacists
por: Booth, Shaid, et al.
Publicado: (2019)

Predicting the response to a triptan in migraine using deep attack phenotyping: A feasibility study
por: Viana, Michele, et al.
Publicado: (2020)

Triptans for Migraine Therapy: A Comparison Based on Number Needed to Treat and Doses Needed to Treat
por: Mullins, C. Daniel
Publicado: (2005)

NSAIDs in the Acute Treatment of Migraine: A Review of Clinical and Experimental Data
por: Pardutz, Arpad, et al.
Publicado: (2010)

Unmet Needs in Japanese Patients Who Report Insufficient Efficacy with Triptans for Acute Treatment of Migraine: Retrospective Analysis of Real-World Data
por: Hirata, Koichi, et al.
Publicado: (2020)

Best Value for Money in Triptans
por: Curtiss, Frederic R.
Publicado: (2005)

Comparison of healthcare resource utilization and costs among patients with migraine with potentially adequate and insufficient triptan response
por: Marcus, Steven C, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_boh0jtsiprproroqjbd4b3rbca